Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China flag China · Delayed Price · Currency is CNY
4.440
+0.010 (0.23%)
Apr 28, 2026, 3:00 PM CST

SHA:600572 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
6,6946,4736,4266,6525,9456,531
Other Revenue
--89.0280.5954.9537.67
6,6946,4736,5156,7336,0006,568
Revenue Growth (YoY)
4.99%-0.64%-3.23%12.21%-8.64%11.15%
Cost of Revenue
3,0853,0233,1012,8352,4702,626
Gross Profit
3,6093,4513,4143,8973,5313,942
Selling, General & Admin
2,6452,5642,4802,8322,5812,964
Research & Development
259.39262.22300.02298.09195.72202.49
Other Operating Expenses
7.810.0252.8-38.4962.9964.65
Operating Expenses
2,9102,8272,8343,0932,8403,268
Operating Income
698.2624.18579.93804.32690.41674.18
Interest Expense
---20.79-36.4-49.47-73.22
Interest & Investment Income
79.2478.01101.92135.2789.352,611
Currency Exchange Gain (Loss)
--5.223.09-1.110.06
Other Non Operating Income (Expenses)
-33.16-32.29-1.06-21.98-3.76-9.31
EBT Excluding Unusual Items
737.74669.9665.22884.3725.423,203
Gain (Loss) on Sale of Investments
25.2964.0230.27-146.04-238.23-714.69
Gain (Loss) on Sale of Assets
4.964.9820.5535.6836.0242.22
Asset Writedown
-98.73-93.74-5.46-7.18-1.84-95.71
Other Unusual Items
--69.360.9368.6492.55
Pretax Income
669.27645.17779.94767.69590.012,527
Income Tax Expense
167.71153.62121.5992.97129.89391.13
Earnings From Continuing Operations
501.56491.55658.35674.72460.122,136
Minority Interest in Earnings
-18.14-17.19-35.94-83.15-102-118.31
Net Income
483.42474.36622.42591.57358.122,017
Net Income to Common
483.42474.36622.42591.57358.122,017
Net Income Growth
-18.86%-23.79%5.21%65.19%-82.25%345.06%
Shares Outstanding (Basic)
2,5012,4972,5272,5722,5582,586
Shares Outstanding (Diluted)
2,5012,4972,5312,5722,5582,586
Shares Change (YoY)
-3.29%-1.37%-1.59%0.55%-1.10%2.71%
EPS (Basic)
0.190.190.250.230.140.78
EPS (Diluted)
0.190.190.250.230.140.78
EPS Growth
-16.10%-22.86%7.09%64.29%-82.05%333.33%
Free Cash Flow
878.62795.35721.9689.5863.73309.8
Free Cash Flow Per Share
0.350.320.280.270.340.12
Dividend Per Share
--0.1500.2000.1500.160
Dividend Growth
---25.00%33.33%-6.25%-
Gross Margin
53.91%53.31%52.41%57.88%58.84%60.02%
Operating Margin
10.43%9.64%8.90%11.95%11.51%10.26%
Profit Margin
7.22%7.33%9.55%8.79%5.97%30.72%
Free Cash Flow Margin
13.13%12.29%11.08%10.24%14.39%4.72%
EBITDA
1,040964.42913.751,129963.34956.65
EBITDA Margin
15.54%14.90%14.03%16.76%16.05%14.56%
D&A For EBITDA
341.84340.23333.82324.35272.93282.47
EBIT
698.2624.18579.93804.32690.41674.18
EBIT Margin
10.43%9.64%8.90%11.95%11.51%10.26%
Effective Tax Rate
25.06%23.81%15.59%12.11%22.02%15.48%
Revenue as Reported
220.69-6,5156,7336,0006,568
Source: S&P Global Market Intelligence. Standard template. Financial Sources.